Teprenone for the prevention of low-dose aspirin-induced gastric mucosal injury in Helicobacter pylori-negative patients
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Objectives: Low-dose aspirin is the standard treatment for the prevention of cardiovascular events in at-risk patients. We performed a randomized, placebo-controlled study to determine the efficacy of teprenone for primary p...
Saved in:
Main Authors: | , , |
---|---|
格式: | 雜誌 |
出版: |
2020
|
主題: | |
在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074031744&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/67955 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Chiang Mai University |